Survival of Motor Neuron 2 Splicing Modifier

All categories
Name
Survival of Motor Neuron 2 Splicing Modifier
Accession Number
DBCAT005887
Description

Not Available

Drugs
DrugDrug Description
RisdiplamAn oral mRNA splicing modifier used in the treatment of spinal muscular atrophy (SMA).
Drugs & Drug Targets
DrugTargetType
RisdiplamP-glycoprotein 1transporter
RisdiplamATP-binding cassette sub-family G member 2transporter
RisdiplamMultidrug and toxin extrusion protein 1transporter
RisdiplamMultidrug and toxin extrusion protein 2transporter
RisdiplamCytochrome P450 3A Subfamilyenzyme
RisdiplamDimethylaniline monooxygenase [N-oxide-forming] 1enzyme
RisdiplamDimethylaniline monooxygenase [N-oxide-forming] 3enzyme
RisdiplamCytochrome P450 1A1enzyme
RisdiplamCytochrome P450 2J2enzyme
RisdiplamCytochrome P450 3A4enzyme
RisdiplamCytochrome P450 3A7enzyme
RisdiplamSerum albumincarrier